Filters
Results 1 - 10 of 2163
Results 1 - 10 of 2163.
Search took: 0.027 seconds
Sort by: date | relevance |
AbstractAbstract
[en] Neuroblastoma is the most common extracranial solid tumor of a childhood. Neuroblastoma is well known for its variability in clinical behavioral and distinct biological features. In a history of pediatric oncology it is a first disease, where the biological marker (NMYC amplification) was used for a prospective therapeutical randomisation. Current research is focused on detection of a new biological prognostic markers in neuroblastoma and implementation of a new therapeutical approaches into a clinical practise (eg. antiangiogenic therapies, metronomic chemotherapy, biotherapy, immunotherapy. (author)
Original Title
Novinky v diagnostice a lecbe neuroblastomu
Primary Subject
Source
24 refs., 5 figs., 1 tab.
Record Type
Journal Article
Journal
Onkologia (Bratislava); ISSN 1336-8176;
; v. 3(4); p. 257-261

Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
Farella, R.; Dansky, B.; Epifano, L.; Collica, C.
Medi-Ray, Inc., New York (USA)1980
Medi-Ray, Inc., New York (USA)1980
AbstractAbstract
[en] This patent specification relates to a partially disposable shielded syringe for injecting radioactive material into a patient. It is claimed that the technique overcomes the problems of non-standardisation of syringe size. (U.K.)
Primary Subject
Source
30 Jul 1980; 5 p; GB PATENT DOCUMENT 1572650/A/
Record Type
Patent
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] This brief article describes the difference in meaning between maladministration and misadministration of radiopharmaceuticals. Recommendations are given for the management of misadministrations such as extravasated radiopharmaceuticals. (UK)
Primary Subject
Record Type
Journal Article
Journal
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
Villacorta, E.V.
Proceedings of the 1977 joint annual Convention, Radioisotope Society of the Philippines Inc. and the Philippine Society for Nuclear Medicine1977
Proceedings of the 1977 joint annual Convention, Radioisotope Society of the Philippines Inc. and the Philippine Society for Nuclear Medicine1977
AbstractAbstract
[en] The Nuclear Medicine Department of the Philippine Heart Center has introduced the detection of coronary heart disease through myocardiac perfusion imaging. The cardiovascular procedures are availed of free-of-charge to registered PHCA patients excepting for the costly TI-201 imaging. In summary, coronary perfusion in imaging should be an integral part of coronary arteriography. Barring the expensive cost of TI-120, myocardial perfusion imaging is ideal for detection of coronary heart disease. Experience shows better sensitivity of TI-201 than exercise ECG for detection of ischemia. Another non-invasive procedure for the detection of acute infarction is the radionuclide imaging using a bone radiopharmaceutical Tc99m prophosphate. In conclusion, acute infarct imaging is a valuable adjunct to ECG and enzyme studies. (RTD)
Primary Subject
Source
12 p; Nov 1977; p. 3-5; Joint annual convention of the Radioisotope Society of the Philippines Inc. and the Philippine Society for Nuclear Medicine on Radioisotope and the Common Man; Philippines; 11 Nov 1977
Record Type
Miscellaneous
Literature Type
Conference
Report Number
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
No abstract available
Primary Subject
Secondary Subject
Source
Vienna Univ. (Austria). Klinik fuer Strahlentherapie und Strahlenbiologie; 88 p; 1985; p. 11; Third international meeting on progress in radio-oncology; Vienna (Austria); 27-30 Mar 1985; Published in summary form only.
Record Type
Miscellaneous
Literature Type
Conference
Report Number
Country of publication
Reference NumberReference Number
Related RecordRelated Record
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] The metal protective sheath consists of an axially symmetrical cylinder with a ring with notches at the front. A single injection is accommodated in the longitudinal hole of the cylinder, where the wing shape on the injection tube can be completely accommodated in the notches. The injection is therefore fixed axially. (DG)
[de]
Die metallische Schutzhuelse besteht aus einem axialsymmetrischen Zylinder mit einem stirnseitig angebrachten Ring mit Einkerbungen. Im Laengsloch des Zylinders ist die Einmalspritze untergebracht, wobei deren an der Spritztube angeformtem Fluegel vollstaendig in den Einkerbungen aufgenommen werden koennen. Die Spritze ist somit axial festgelegt. (DG)Original Title
Schutzhuelse fuer medizinische Spritzen mit radioaktivem Inhalt
Primary Subject
Source
22 Mar 1984; 26 Oct 1983; 9 p; DE PATENT DOCUMENT 8330756/U1/; Available from Deutsches Patentamt, Muenchen (Germany, F.R.); ?: 26 Oct 1983
Record Type
Patent
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] Primary methods of radionuclidic standardization serve as the underlying basis of the physical measurement standards of activity that are needed in virtually every sub-discipline of radioanalytical and nuclear chemistry. Primary methods refer to the direct measurement of the number of nuclear transformations that occur per unit time, without recourse to other calibrations or standards. Such measurements, leading to the development and dissemination of radioactivity standards, are primarily performed under the purview of national metrology laboratories, like the National Institute of Standards and Technology (NIST) in the USA. This paper briefly reviews some of the various primary methods that have been developed by many such laboratories over many years. Their features and their role in ensuring the quality of radioactivity measurements are highlighted by several primary standardizations that have been recently performed at NIST. (author)
Primary Subject
Source
45 refs.
Record Type
Journal Article
Journal
Journal of Radioanalytical and Nuclear Chemistry; ISSN 0236-5731;
; CODEN JRNCDM; v. 280(2); p. 265-273

Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
Chmielowski, J.; Woznica, A.; Pytlak, M.
Abstracts of the 31. Meeting of the Polish Biochemical Society1995
Abstracts of the 31. Meeting of the Polish Biochemical Society1995
AbstractAbstract
[en] Short communication
Original Title
Mechanizm akumulacji uranu przez immobilizowane komorki bakterii izolowanych ze zloza uranonosnego
Primary Subject
Secondary Subject
Source
Polish Biochemical Society, Warsaw (Poland); 179 p; 1995; p. 53B; Polskie Towarzystwo Biochemiczne; Warsaw (Poland); 31. Meeting of the Polish Biochemical Society; 31. Zjazd Polskiego Towarzystwa Biochemicznego; Warsaw (Poland); 6-8 Sep 1995; Available from Institute of Nuclear Chemistry and Technology, Dept. of Radiobiology and Health Protection, 16, Dorodna St., 03-195 Warsaw, Poland
Record Type
Miscellaneous
Literature Type
Conference
Country of publication
Reference NumberReference Number
Related RecordRelated Record
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] Full text: After giving first dose of radionuclide pain palliation therapy in 20 patients, re-therapy was considered again in these patients. 2nd therapy was done in 20 patients followed by 3rd therapy in 11 of them which was subsequently followed by 4th therapy in 4 patients (total 35 re-therapy doses). Phosphorus-32 was used in a mean dose 6.15 mCi (4.5-7 mCi) in 15 pts. and Samarium-153, 60 mCi (45-95 mCi) in 20 therapies. Strict follow up data was available in all patients. Mean follow up duration was 13.75 months (6 month - 20 months). Re-therapy was done after an interval of 4.7 months on an average. Pre-treatment pain score and narcotic score were 6.8 and 3.5. Average Hemoglobin, white blood cell and platelet count was 11.2, 8,600 and 1,89,000 respectively. After administration of radionuclide therapy there was a predictive but fully recovered fall in platelet counts only. It decreased to a mean 1,63,000 at around 4-5 weeks. Post-treatment pain score and narcotic score were 4.1 and 2.5 (P<0.005 as compared with pretreatment level). No serious toxicity was noted in any patient. Radionuclide pain palliation remains a very safe and effective option. Retherapy can be done very easily will equally good effects. No hematological toxicity was seen in any of the patient
Primary Subject
Source
SNMICON-2010: 42. annual conference of the Society of Nuclear Medicine (India) on molecular imaging and targeted radionuclide therapy: predicting the future; Chandigarh (India); 11-14 Nov 2010
Record Type
Journal Article
Literature Type
Conference
Journal
Indian Journal of Nuclear Medicine; CODEN IJNMEK; v. 25(3); p. 119
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
No abstract available
Original Title
Obtencao de imagem em medicina nuclear usando dosimetria termoluminescente (TLD)
Secondary Subject
Source
39. Annual Meeting of the Brazilian Society for the Advancement of Science; Brasilia, DF (Brazil); 12-18 Jul 1987; Published in summary form only.
Record Type
Journal Article
Literature Type
Conference
Journal
Country of publication
LanguageLanguage
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
1 | 2 | 3 | Next |